1. Circulating T cells to infliximab are detectable mainly in treated patients developing anti-drug antibodies and hypersensitivity reactions. (26th October 2016) Authors: Vultaggio, A; Petroni, G; Pratesi, S; Nencini, F; Cammelli, D; Milla, M; Prignano, F; Annese, V; Romagnani, S; Maggi, E; Matucci, A Journal: Clinical and experimental immunology Issue: Volume 186:Number 3(2016:Dec.) Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗